Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\LNDC · Entity 6447 | Chief Operations Officer | April 03, 2018 | May 30, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LIFECORE BIOMEDICAL, INC. \DE\
Report date April 03, 2018 · Filed May 30, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,041 |
Reported balance
After 2018-04-03 transaction · row 1
1 source rowRow 1 · 2018-04-03 · Gift · Acquired 4,528 · Balance 70,041 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2018 Filed May 25, 2018 21:34 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010765 · rdgdoc.xml · derivative · entry 3 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28, 2015. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:34 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 3,416 | $13.65 | $46,628.40 |
DisclosureSEC source: 0001437749-18-010765 · rdgdoc.xml · nonDerivative · entry 2 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,513 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:34 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 10,000 | $13.65 | $136,500.00 |
DisclosureSEC source: 0001437749-18-010765 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 09, 2018 Filed May 10, 2018 22:03 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 9,239 | $13.36 | $123,433.04 |
DisclosureSEC source: 0001437749-18-009482 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,929 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.475, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 25, 2018 Filed Apr 27, 2018 20:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 163 | $13.85 | $2,257.55 |
DisclosureSEC source: 0001437749-18-007974 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,168 Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 21:35 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 1,132 | $13.86 | $15,689.52 |
DisclosureSEC source: 0001437749-18-007499 · rdgdoc.xml · nonDerivative · entry 2 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,331 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.85 to $13.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 21:35 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 3,499 | $13.88 | $48,566.12 |
DisclosureSEC source: 0001437749-18-007499 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,463 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.85 to $13.907, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 18, 2018 Filed Apr 19, 2018 17:46 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 12,179 | $13.92 | $169,531.68 |
DisclosureSEC source: 0001437749-18-007175 · rdgdoc.xml · nonDerivative · entry 2 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,962 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.85 to $14.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 17:46 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 1,271 | $14.00 | $17,794.00 |
DisclosureSEC source: 0001437749-18-007175 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,141 Read SEC document |
| April 06, 2018 Filed Apr 9, 2018 21:07 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 2,517 | $14.02 | $35,288.34 |
DisclosureSEC source: 0001437749-18-006577 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,412 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14 to $14.055, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| April 03, 2018 Filed May 30, 2018 19:59 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GiftCommon Stock | 4,528 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010918 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,041 Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 7,145 | $13.00 Strike: $13.00 | $92,885.00 |
DisclosureSEC source: 0001437749-17-017447 · rdgdoc.xml · derivative · entry 5 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,145 Underlying: Common Stock · 7,145 shares Expires 2017-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 2,685 | $13.00 | $34,905.00 |
DisclosureSEC source: 0001437749-17-017447 · rdgdoc.xml · nonDerivative · entry 2 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,929 Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 7,145 | $13.00 | $92,885.00 |
DisclosureSEC source: 0001437749-17-017447 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-017447 · rdgdoc.xml · derivative · entry 4 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 15,000 | $12.65 Strike: $12.65 | $189,750.00 |
DisclosureSEC source: 0001437749-17-017447 · rdgdoc.xml · derivative · entry 3 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 15,000 shares Expires 2024-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 11, 2017 Filed Apr 12, 2017 18:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 20,000 | $13.76 | $275,200.00 |
DisclosureSEC source: 0001437749-17-006499 · rdgdoc.xml · nonDerivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,469 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.75 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 23:50 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 7,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-16-040137 · rdgdoc.xml · derivative · entry 2 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,145 Underlying: Common Stock · 7,145 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 23:50 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 7,145 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-16-040137 · rdgdoc.xml · derivative · entry 1 Midyett Ronald Lane · CIK 0001423531 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,145 Underlying: Common Stock · 7,145 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F3 · derivative.expiration_date: Restricted Stock Units will vest on the 2nd anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.